Kits Eyecare (TSX: KITS) has released preliminary data on its first quarter results this morning, indicating that it continues to see substantial growth on a year over year basis.

Revenue in the first quarter is said to have grown to $46.6 million, a 34% improvement over the $34.8 million in revenue reported in the first quarter of 2024.

Adjusted EBITDA meanwhile is said to have hit record levels, and is expected to have exceeded 7.0% of revenue. The figure implies Adjusted EBITDA of approximately $3.3 million, which compares to the year ago period that posted just $0.6 million in Adjusted EBITDA for the quarter. The company had previously guided to Adjusted EBITDA in a range of 6% to 8% of revenue.

The company meanwhile is reporting that it ended the quarter with $17.5 million in cash on hand.

Full financial results for Q1 are scheduled to be released in early May.

Kits Eyecare last traded at $10.47 on the TSX.

Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.